Unique ID issued by UMIN | UMIN000010604 |
---|---|
Receipt number | R000012398 |
Scientific Title | Efficacy and safety of treatment with Azilsartan in type 2 diabetes mellitus patients with hypertension who did not show target blood pressure by telmisartan. |
Date of disclosure of the study information | 2013/05/01 |
Last modified on | 2015/04/28 06:52:33 |
Efficacy and safety of treatment with Azilsartan in type 2 diabetes mellitus patients with hypertension who did not show target blood pressure by telmisartan.
Study of Switching to Azilsartan from Telmisartan in type 2 diabetes mellitus patients
Efficacy and safety of treatment with Azilsartan in type 2 diabetes mellitus patients with hypertension who did not show target blood pressure by telmisartan.
Study of Switching to Azilsartan from Telmisartan in type 2 diabetes mellitus patients
Japan |
Type 2 diabetes mellitus with hypertension
Endocrinology and Metabolism |
Others
NO
To examinate efficacy and safty of treatment with Azilsartan in type 2 diabetes mellitus patients who did not show target blood pressure by Telmisartan
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
blood pressure and HbA1c at 0, 4, 8, and 12 weeks after starting of treatment
AST, ALT, gamma-GTP, LDL, HDL, TG, fasting glucose, adiponectin, safty at 0, 4, 8, and 12 weeks after starting of treatment
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
switching to Azilsartan
20 | years-old | <= |
Not applicable |
Male and Female
All patients with type 2 diabetes mellitus with hypertension vistited our Hospital and approved with this study.
They who were being treated with telmisartan 40mg at least for 8 weeks did not reached aim of decrease of blood pressure.
Medication other than antihypertensive drug was not changed for 8weeks.
1)patients who wrere poorly controlled .
2)patients with secondary hypertension.
3)patients on HD.
4)pregnant patients.
5)patients who wrere allergic to telmisartan.
6)patients with heavy liver dysfunction.
7)patients with heavy renal dysfunction(Cre>3mg/dL).
20
1st name | |
Middle name | |
Last name | Tomoyuki Iwasaki |
Iwasaki Naika Clinic
Internal medicien
1-1-5-1F Kamihoshikawa, Hodogaya-ku, Yokohama
045-442-6475
toiwasaki-dm@umin.ac.jp
1st name | |
Middle name | |
Last name | Satoko Ono |
Iwasaki Naika Clinic
Internal medicien
1-1-5-1F Kamihoshikawa, Hodogaya-ku, Yokohama
045-442-6475
toiwasaki-dm@umin.ac.jp
Iwasaki Naika Clinic
None
Self funding
NO
2013 | Year | 05 | Month | 01 | Day |
Published
Completed
2013 | Year | 05 | Month | 01 | Day |
2013 | Year | 05 | Month | 01 | Day |
2014 | Year | 05 | Month | 01 | Day |
2014 | Year | 06 | Month | 01 | Day |
2014 | Year | 06 | Month | 01 | Day |
2014 | Year | 06 | Month | 01 | Day |
2013 | Year | 04 | Month | 27 | Day |
2015 | Year | 04 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012398
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |